Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.42 |
| ▸ | CETP | P11597 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SIRT2 | Q8IXJ6 | 5/20 | 0.40 |
| ▸ | SIRT1 | Q96EB6 | 4/20 | 0.40 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22181023 | 1.00 | ALDH1A1 (0.44) | ALDH1A1MEN1HPGDKMT2AMBOAT4 | |
| SCHEMBL20966572 | 0.96 | ALDH1A1 (0.41) | ALDH1A1MEN1HPGDKMT2AMBOAT4 | |
| SCHEMBL18196801 | 0.91 | ALDH1A1 (0.42) | ALDH1A1MEN1HPGDKMT2AMAPK1 | |
| SCHEMBL9069103 | 0.84 | ZDHHC2 (0.39) | ALDH1A1L3MBTL1SIRT2 | |
| SCHEMBL16245288 | 0.81 | SLC15A1 (0.44) | ALDH1A1MAPK1L3MBTL1 | |
| SCHEMBL31674546 | 0.80 | ALDH1A1 (0.50) | ALDH1A1MEN1HPGDKMT2ACETP | |
| SCHEMBL16614401 | 0.80 | ALDH1A1 (0.39) | ALDH1A1HPGDMBOAT4MAPK1L3MBTL1 | |
| SCHEMBL16614382 | 0.80 | ALDH1A1 (0.39) | ALDH1A1MAPK1L3MBTL1CYP3A4 | |
| SCHEMBL3648854 | 0.80 | ATM (0.40) | MBOAT4 | |
| SCHEMBL22406078 | 0.79 | PLA2G10 (0.38) | CETPL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230227489-A1 | GLYCOLIPOPEPTIDE BIOSURFACTANTS | CRODA INTERNATIONAL PLC (GB) | 2023-07-20 | — | — | US | disclosed |
| EP-3440179-B1 | GLYCOLIPOPEPTIDE BIOSURFACTANTS | CRODA INT PLC (GB) | 2020-06-03 | — | — | EP | disclosed |
| US-20190127411-A1 | GLYCOLIPOPEPTIDE BIOSURFACTANTS | CRODA INTERNATIONAL PLC (GB) | 2019-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190127411-A1 | GLYCOLIPOPEPTIDE BIOSURFACTANTS | LYPLAL1, LNPEP, PHOSPHO1 | ALDH1A1 4821/4885MEN1 3600/4885HPGD 3188/4885 |
| US-20230227489-A1 | GLYCOLIPOPEPTIDE BIOSURFACTANTS | LYPLAL1, LNPEP, PHOSPHO1 | ALDH1A1 4821/4885MEN1 3600/4885HPGD 3188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.